Strategy Asset Managers »

Vaneck Vectors Pharmaceutical etf shares owned by Strategy Asset Managers

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Strategy Asset Managers from 13F filings

Historical chart of Strategy Asset Managers investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Strategy Asset Managers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Strategy Asset Managers

Quarter filed Position value Share count Share price at filing
2025-12-31 $200k 1.9k 103.17

More positions owned by Strategy Asset Managers

Broadcom (AVGO)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Cisco Systems (CSCO)
Apple (AAPL)
Johnson & Johnson (JNJ)
Constellation Energy (CEG)
Lockheed Martin Corporation (LMT)
Emerson Electric (EMR)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Wal-Mart Stores (WMT)
Kinder Morgan (KMI)
Chevron Corporation (CVX)

View all positions for Strategy Asset Managers

Top funds holding Vaneck Vectors Pharmaceutical etf

Healthcare Of Ontario Pension Plan Trust Fund
Goldman Sachs Group
British Columbia Investment Management Corporation
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Bnp Paribas Arbitrage, Snc
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Adamsbrown Wealth Consultants
Susquehanna International
UBS Group
LPL Financial

View all funds holding Vaneck Vectors Pharmaceutical etf